Document Detail


Role of the selective aldosterone receptor blockers in arterial hypertension.
MedLine Citation:
PMID:  15136969     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Aldosterone can cause cardiovascular injury in animals and men. The aldosterone blocker, spironolactone, has been shown to reduce mortality in patients with congestive heart failure. The use of this drug in arterial hypertension has been limited by the high frequency of adverse effects. Recently published data with a new aldosterone blocker, eplerenone, have confirmed the benefits of aldosterone blockade in patients post-myocardial infarction, as well as in the regression of left ventricular hypertrophy in hypertensive patients and of microalbuminuria in Type 2 diabetic patients. The fact that eplerenone is much better tolerated open the possibility of this therapy in cardiovascular, as well as in renal disease.
Authors:
Cristina Sierra; Luis M Ruilope
Related Documents :
19168509 - Inflammation as a therapeutic target in heart failure? a scientific statement from the ...
8181019 - Blockade of the renin-angiotensin system. effect on mortality in patients with left ven...
15038409 - Levosimendan: first in a new class of inodilator for acute and chronic severe heart fai...
19147689 - Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review ...
12589189 - Metabolic and nutritional support in acute cardiac failure.
8772689 - Prognostic significance of plasma norepinephrine in patients with asymptomatic left ven...
21034659 - Cholinergic anti-inflammatory pathway: a possible approach to protect against myocardia...
7247069 - Abnormal left ventricular contraction revealed by impedance cardiograms and arterial tr...
9137299 - Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of the renin-angiotensin-aldosterone system : JRAAS     Volume:  5     ISSN:  1470-3203     ISO Abbreviation:  J Renin Angiotensin Aldosterone Syst     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-05-11     Completed Date:  2004-10-19     Revised Date:  2013-11-25    
Medline Journal Info:
Nlm Unique ID:  100971636     Medline TA:  J Renin Angiotensin Aldosterone Syst     Country:  England    
Other Details:
Languages:  eng     Pagination:  23-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Humans
Hypertension / drug therapy*
Mineralocorticoid Receptor Antagonists*
Myocardial Infarction / complications
Spironolactone / analogs & derivatives*,  therapeutic use*
Ventricular Dysfunction, Left / drug therapy,  etiology
Chemical
Reg. No./Substance:
0/Mineralocorticoid Receptor Antagonists; 27O7W4T232/Spironolactone; 6995V82D0B/eplerenone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blood pressure in haemodialysis patients: the importance of the relationship between the renin-angio...
Next Document:  Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, a...